Company Updates

Artists Impression of Mighty High Aerial Park Source: The Sydney Morning Herald ITS film festival ran into trouble late last year but Cockatoo Island could be getting an adventure park. The founder of Mighty High Aerial Adventure Park, Marcus Jaackson, is planning an attraction that will feature ”high-ropes courses”, suspension bridges, parachute-style drops and zip […]

PERTH, AUSTRALIA: February 05, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that it has entered an agreement with Bio-Link Australia Pty. Ltd., a specialist life sciences business development company, to commercialise a family of anti-inflammatory PhylomerÒ peptides for pharmaceutical use. Under the terms of the […]

PERTH, AUSTRALIA: January 31, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the extension of its collaboration with Janssen Biotech, Inc. and its affiliates (“Janssen”) to discover, develop and commercialise new classes of peptide-drug conjugates derived from Phylogica’s Phylomer® drug discovery platform. Phylogica has received an […]

2012 saw a stellar year for listed property groups. According to Ken Howard of RBS Morgans, “Property trusts performed very strongly in 2012, with the A-REITs sector outperforming the ASX 200 index by around 9 per cent for the year ended.” With a reduction in interest rates, the sector has seen superior yields on offer from investments that […]

The Directors of Oil Basins Limited (OBL, ASX codes OBL and OBLOB, or the Company) are pleased to make the following ASX announcement. As the Company anticipates that it will soon be awarded at least 50% of petroleum exploration permit 5/07-8EP (Derby Block), refer to Figures 1 & 2, OBL has arranged a modest capital raising, with the […]

Sydnet, Australia 24th January 2013-NuSep (ASX: NSP) wishes to advise the market that it has received an unsolicited offer to acquire the non-core assets of its ProteolQ software business. The Compnay has negotiated the sale of this software with the Palo Alto, California based PREMIER Biosoft. PREMIER Biosoft is a leading provider of software solutions […]

Anti-midkine antibodies reduced mortality rate and preserved kidney function in a mouse model of diabetic nephropathy Kidney damage markedly reduced in treated animals Additional data bolsters preclinical antibody data package Large unmet medical need for patients with kidney disease SYDNEY, Wednesday, 23 January 2013: Cellmid Limited (ASX: CDY) has completed its first in-life diabetic nephropathy […]

By: Howard Moodycliffe DriveMyCar Rentals (DMCR) has made significant progress with securing additional vehicles to meet some of the strong demand that has been experienced by the business. Two sets of investors have agreed to provide a total of $2.5m in vehicles over several months to service long-term rental demand. A pool of individual vehicle investors […]

Patent for the use of anti-midkine agents to prevent and treat blood vessel obstruction allowed in Europe  Further IP protection for Cellmid in cardiovascular diseases and in midkine inhibitors  Composition of matter for siRNA molecules targeting midkine also covered  SYDNEY, 21 January 2013: Cellmid Limited (ASX: CDY) advises that the European Patent Office (EPO) has issued a […]